ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 031,39
-0,42%
Dow Jones
38 386,09
0,00%
DAX
17 992,06
-0,77%
Brent Oil
87,555
0,31%
Bitcoin
61 151,41
-4,21%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) Actualités

ASMB Assembly Biosciences Inc

12,90
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:15
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Assembly Biosciences Inc ASMB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 12,90 13:00:15
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
12,90
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/3/202421:05GLOBEAssembly Biosciences Reports Fourth Quarter and Year End..
08/2/202414:00GLOBEAssembly Biosciences Announces Effective Date of Reverse..
02/2/202422:05EDGAR2Form 8-K - Current report
19/1/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:05EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEAssembly Biosciences Provides Anticipated Development..
21/12/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
11/12/202322:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/12/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:05EDGAR2Form 8-K - Current report
22/11/202322:12EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202322:05GLOBEAssembly Biosciences Reports Inducement Grant Under Nasdaq..
10/11/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Viral..
08/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEAssembly Biosciences Reports Third Quarter 2023 Financial..
08/11/202314:00GLOBEAssembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief..
03/11/202321:05EDGAR2Form SC 13D/A - General statement of acquisition of..
31/10/202321:19EDGAR2Form SC 13D - General statement of acquisition of beneficial..
31/10/202317:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/10/202314:44DJNAssembly Biosciences Shares Soar Premarket on Gilead Pact
17/10/202313:51DJNGilead Taking Stake in Assembly Bio Under Antiviral..
17/10/202313:10EDGAR2Form 8-K - Current report
17/10/202313:00BWGilead and Assembly Biosciences Establish Partnership to..
11/10/202314:00GLOBEAssembly Biosciences to Present New Data at AASLD The Liver..
04/10/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:20EDGAR2Form 144 - Report of proposed sale of securities
04/10/202301:18EDGAR2Form 144 - Report of proposed sale of securities
02/10/202314:00GLOBEAssembly Biosciences Nominates Development Candidate..
19/9/202322:05GLOBEAssembly Biosciences to Highlight Pipeline Progress in HBV..
19/9/202300:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202322:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:12EDGAR2Form 8-K - Current report
09/8/202322:05GLOBEAssembly Biosciences Reports Second Quarter 2023 Financial..
07/8/202322:05EDGAR2Form 8-K - Current report
03/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202300:04EDGAR2Form 144 - Report of proposed sale of securities
03/8/202300:01EDGAR2Form 144 - Report of proposed sale of securities
25/7/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Herpes..
21/6/202314:00GLOBEAssembly Biosciences Presents New Data Highlighting Entry..
07/6/202314:00GLOBEAssembly Biosciences to Present Data at Upcoming..
23/5/202322:05GLOBEAssembly Biosciences to Present During the 2023 Jefferies..
04/5/202322:05GLOBEAssembly Biosciences Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
ASMB
Assembly Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés